期刊文献+

老年慢性肾脏病肾小球滤过率与胱抑素C及同型半胱氨酸的相关性研究

Correlation between Glomerular Filtration Rate and Cystatin C and Homocysteine in Elderly Patients with Chronic Kidney Disease
下载PDF
导出
摘要 目的分析老年慢性肾脏病(chronic kidney disease,CKD)患者肾小球滤过率(glomerular filtration rate,GFR)、胱抑素C(CystatinC,CysC)和同型半胱氨酸(Homocysteine,Hcy)的相关性。方法方便选取该院在2016年12月-2018年12月共收治94例慢性肾病老年患者,依据肾小球滤过率分为早期组(GFR≥60 mL/min,n=54)和晚期组(GFR<60mL/min,n=40),对比两组CysC、Hcy变化和肾小球滤过率的关联性。结果早期组和晚期组身体质量指数(24.6±3.58)kg/m^2 vs(25.25±2.67)kg/m^2、HbA1c(8.50±2.02)%vs (8.92±2.24)%,差异无统计学意义(P>0.05),CysC(1.73±1.01)mg/L高于早期组的(0.84±0.27)mg/L,差异有统计学意义(t=6.193,P<0.05),两组Hcy (13.05±6.05)μmol/L vs (15.45±5.65)μmol/L对比,差异无统计学意义(P>0.05)。所有患者中,GFR和CysC、Hcy呈现为负相关。在CKDⅡ期、Ⅲ期患者中,GFR和CysC、HCy呈现为负相关。结论慢性肾病患者中,CysC、Hcy逐渐上升,特别在CKDⅡ、Ⅲ期,CysC、Hcy联合测定对比,能够较好地反映出慢性肾脏病肾小球滤过率功能障碍。 Objective Analysis of elderly chronic kidney disease(chronic kidney diseases,CKD) in patients with glomerular filtration rate(glomerular filtration rate,GFR) urinary inhibition,Cystatin C(CystatinC,CysC) and Homocysteine(Homocysteine,Hcy) relevance.Methods convenient selection of 94 elderly patients with chronic kidney disease were enrolled in the hospital from December 2016 to December 2018 According to the glomerular filtration rate,the patients were divided into the early group(GFR≥60 mL/min,n=54) and the late group(GFR<60 mL/min,n=40),the correlation between CysC,Hcy changes and glomerular filtration rate was compared between the two groups.Results There were no significant differences in body mass index(24.6±3.58)kg/m^2 vs(25.25±2.67) kg/m^2 and HbAlc(8.50±2.02)% vs(8.92±2.24)%between the early and late groups,the difference was not statistically significant(P>0.05).CysC(1.73±1.01) mg/L,was higher than that of the early group(0.84±0.27)mg/L,and the comparison between groups was statistically significant(t=6.193,P<0.05).There was no difference in homocysteine(Hcy)(13.05±6.05)μmol/L vs(15.45±5.65)μmol/L between the two groups(P>0.05).All the patients,the GFR and CysC,Hcy were negatively correlated.In the CKD stage II and III patients,the Hcy confirmed that GFR was negatively correlated with CysC and Hcy.Conclusion CysC,Hcy are gradually increased in patients with chronic kidney disease,especially in CKDII,III,CysC,Hcy combined,which can better reflect the glomerular filtration rate dysfunction of chronic kidney disease.
作者 崔惠芬 高土明 尹雪彬 石波 CUI Hui-fen;GAO Tu-ming;YIN Xue-bin;SHI Bo(Department of Internal Medicine,Liaobu Hospital of Guangdong Medical University,Dongguan,Guangdong Province,523400 China;Department of Emergency,Liaobu Hospital of Guangdong Medical University,Dongguan,Guangdong Province,523400 China;Department of Severe Medical,Liaobu Hospital of Guangdong Medical University,Dongguan,Guangdong Province,523400 China)
出处 《中外医疗》 2020年第5期20-21,32,共3页 China & Foreign Medical Treatment
基金 东莞市科技局社会科技发展项目(201950715039928)。
关键词 慢性肾脏病 血清胱抑素 同型半胱氨酸 肾小球滤过率 Chronic kidney disease Serum cystatin Homocysteine Glomerular filtration rate
  • 相关文献

参考文献8

二级参考文献96

  • 1刘力生.中国高血压防治指南2010[J].中国医学前沿杂志(电子版),2011,3(5):42-93. 被引量:1221
  • 2李莉,徐迎红,徐燕,苏克文,周茂松.老年高血压患者颈动脉粥样硬化与心血管危险因素分析[J].实用心脑肺血管病杂志,2010,18(12):1763-1765. 被引量:26
  • 3杨慧霞.妊娠合并糖尿病临床诊断与治疗推荐指南(草案)[J].中国实用妇科与产科杂志,2007,23(6):475-477. 被引量:368
  • 4中华人民共和国卫生部.中药新药临床研究指导原则[S].,1997.147.
  • 5Fehrman-Ekholm I,Seeberger A, Bjiorkj, et al. Serum cystatin C.. a useful marker of kidney function in very old people. Scand J Clin Lab Invest, 2009,69 : 606-611.
  • 6Weomegt LS,Prates AB,do Amaral FB, et al. Gender does notinfluence cystatin C concerntrations in healthy volunteers. Clin Chem Ldb Med, 201 O, 48 .. 405-408.
  • 7Choe JY,Park SH,Kim SK. Serum cystatin C is a potential en- dogenous marker for the estimation of renal function in male gout patients with renal impairment. J Korean Med Sei, 2010, 25:42-48.
  • 8Kanwar YS, Wada J, Sum L, et al. Diabetic nephropathy., mech- anisms of renal disease progression. Exp Bio Med(Maywood), 2008,233:4-11.
  • 9Ogawa Y, Goto T,Tzmasawa N, et al. Serum cystatin C in dia- betic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardio- vascular events in patients without nephnopathy. Diabetes Res Clin Pract, 2008,79 .- 357-361.
  • 10Jeon YK,Kim MR, Huh JE, et al. Cystatin C as an early bio- marke of nephropathy in patients with type 2 diabetes. J Kore an Med Sci,2011,26258-263.

共引文献161

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部